PD318088 is a non-ATP competitive, allosteric inhibitor of MEK1/2. It binds to a site adjacent to the ATP-binding pocket, allowing simultaneous occupancy with ATP. This compound is a valuable research tool for investigating the MAPK/ERK pathway in both cellular and animal models of cancer and proliferative diseases.